Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Kohn

Showing results (461-470 of 516) with videos related to

Pageof 52
Sort By:
Cell Reports. Medicine|November 29, 2021
Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapyYan-Ruide Li, Yang Zhou, Yu Jeong Kim, et al.
Cell Reports|March 30, 2021
Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replicationGustavo Garcia, Arun Sharma, Arunachalam Ramaiah, et al.
Blood Advances|December 7, 2019
End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settingsAnn T Farrell, Julie Panepinto, Ankit A Desai, et al.
Blood|May 6, 2018
B-cell differentiation and IL-21 response in <i>IL2RG/JAK3</i> SCID patients after hematopoietic stem cell transplantationAlexandra M Miggelbrink, Brent R Logan, Rebecca H Buckley, et al.
Clinical Immunology (Orlando, Fla.)|December 19, 2025
Clinical spectrum of Wiskott-Aldrich syndrome carriers: Self-reported survey of 193 carriersShanmuganathan Chandrakasan, Adrianna Westbrook, Linda M Griffith, et al.
Blood|June 3, 2026
Long-term stability of posttranscriptional genetic silencing of BCL11A using a shmiR vector in Sickle Cell DiseaseErica B Esrick, Leslie Lehmann, Amy Federico, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 15, 2022
Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trialsKenneth Cornetta, Jing Yao, Kimberley House, et al.
The New England Journal of Medicine|April 30, 2025
Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1Claire Booth, Julián Sevilla, Elena Almarza, et al.
Obstetrical & Gynecological Survey|December 30, 2025
Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1Claire Booth, Julián Sevilla, Elena Almarza, et al.
The New England Journal of Medicine|October 15, 2025
Long-Term Safety and Efficacy of Gene Therapy for Adenosine Deaminase DeficiencyClaire Booth, Katelyn Masiuk, Konstantinos Vazouras, et al.
Pageof 52

Showing results (461-470 of 516) with videos related to

Sort By:
Pageof 52
Cell Reports. Medicine|November 29, 2021
Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapyYan-Ruide Li, Yang Zhou, Yu Jeong Kim, et al.
Cell Reports|March 30, 2021
Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replicationGustavo Garcia, Arun Sharma, Arunachalam Ramaiah, et al.
Blood Advances|December 7, 2019
End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settingsAnn T Farrell, Julie Panepinto, Ankit A Desai, et al.
Blood|May 6, 2018
B-cell differentiation and IL-21 response in <i>IL2RG/JAK3</i> SCID patients after hematopoietic stem cell transplantationAlexandra M Miggelbrink, Brent R Logan, Rebecca H Buckley, et al.
Clinical Immunology (Orlando, Fla.)|December 19, 2025
Clinical spectrum of Wiskott-Aldrich syndrome carriers: Self-reported survey of 193 carriersShanmuganathan Chandrakasan, Adrianna Westbrook, Linda M Griffith, et al.
Blood|June 3, 2026
Long-term stability of posttranscriptional genetic silencing of BCL11A using a shmiR vector in Sickle Cell DiseaseErica B Esrick, Leslie Lehmann, Amy Federico, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 15, 2022
Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trialsKenneth Cornetta, Jing Yao, Kimberley House, et al.
The New England Journal of Medicine|April 30, 2025
Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1Claire Booth, Julián Sevilla, Elena Almarza, et al.
Obstetrical & Gynecological Survey|December 30, 2025
Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1Claire Booth, Julián Sevilla, Elena Almarza, et al.
The New England Journal of Medicine|October 15, 2025
Long-Term Safety and Efficacy of Gene Therapy for Adenosine Deaminase DeficiencyClaire Booth, Katelyn Masiuk, Konstantinos Vazouras, et al.
Pageof 52